<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04963101</url>
  </required_header>
  <id_info>
    <org_study_id>ZDWY.CSYGJWK.003</org_study_id>
    <nct_id>NCT04963101</nct_id>
  </id_info>
  <brief_title>RNA-seq Analysis of PBMC in Patients With OPLL</brief_title>
  <official_title>Characteristics of Transcriptome Expression Profile of PBMCs in Patients With Ossification of the Posterior Longitudinal Ligament</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fifth Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fifth Affiliated Hospital, Sun Yat-Sen University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, we planned to identify transcriptome expression profiles (circRNAs, lncRNAs,&#xD;
      and mRNAs) from peripheral blood mononuclear cells (PBMCs) of 30 patients with OPLL and 30&#xD;
      other non-OPLL patients by high-throughput sequencing.Sequence analysis was used to predict&#xD;
      miRNAs that might bind circRNAs and lncRNAs.Through bioinformatics analysis, competitive&#xD;
      endogenous RNAs (cerRNAs), as well as coexpression networks among circRNAs, lncRNAs, miRNAs,&#xD;
      and mRNAs, were constructed to provide key molecules and signaling pathways associated with&#xD;
      OPLL.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 25, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 25, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>circRNA, lncRNA, mRNA</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>OPLL</condition>
  <condition>PBMCs</condition>
  <condition>Transcriptome</condition>
  <condition>Bioinformatics</condition>
  <eligibility>
    <study_pop>
      <textblock>
        A total of 30 peripheral blood samples were enrolled in this study, including 15 cases in&#xD;
        the OPLL disease group and 15 cases in the non-OPLL control group.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Voluntarily participate in the clinical study and sign the informed consent;&#xD;
&#xD;
          2. All OPLL patients meet the diagnostic criteria set out in the JOA Clinical Practice&#xD;
             Guidelines for Spinal Ligament Osification 2019;&#xD;
&#xD;
          3. Age â‰¥18, gender unlimited;&#xD;
&#xD;
          4. All non-OPLL patients and healthy volunteers have no serious diseases of the heart,&#xD;
             lung, brain, liver, kidney and blood system, such as autoimmune diseases, tumors,&#xD;
             psychosis, infectious diseases, etc., and have no bad habits or recent history of&#xD;
             taking special drugs.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Unable to sign the informed consent;&#xD;
&#xD;
          2. Patients who do not meet the inclusion criteria or diagnostic criteria;&#xD;
&#xD;
          3. &lt;18 years old;&#xD;
&#xD;
          4. Women planning to become pregnant/lactating/pregnant;&#xD;
&#xD;
          5. Complicated with serious heart, lung, brain, liver, kidney, blood system diseases,&#xD;
             such as autoimmune diseases, tumors, mental illness, infectious diseases, drug&#xD;
             addiction and other bad addicts;Those who have recently taken special drugs;&#xD;
&#xD;
          6. Individuals who do not agree to donate peripheral blood or who are obviously&#xD;
             uncomfortable with drawing blood.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Ning Jiang, M.D</last_name>
    <phone>+86 15653868023</phone>
    <email>jiangn57@mail2.sysu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Facility</name>
      <address>
        <city>Zhuhai</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ning Jiang</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 2, 2021</study_first_submitted>
  <study_first_submitted_qc>July 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 15, 2021</study_first_posted>
  <last_update_submitted>July 7, 2021</last_update_submitted>
  <last_update_submitted_qc>July 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fifth Affiliated Hospital, Sun Yat-Sen University</investigator_affiliation>
    <investigator_full_name>Huading Lu</investigator_full_name>
    <investigator_title>Director of orthopaedics</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

